Primary Care POC Diagnostics Market - Forecast(2024 - 2030)

Report Code: HCR 86227 Report Format: PDF + Excel

Primary Care POC Diagnostics Market Overview

Primary Care POC Diagnostics Market size is estimated to reach $8.9 billion by 2026, growing at a CAGR of 3.5% during the forecast period 2021-2026. Point-of-Care (POC) Diagnostics allows physicians to accurately achieve real-time and quality diagnostic results within minutes rather than hours. POC diagnostics at primary care is essential for the rapid detection of analytes to the patient that facilitates better disease monitoring and management. These diagnostics ensure the patients receive the most efficient care and enable staff to make rapid treatment decisions. Rise in the adoption of self-glucose testing devices in developed nations to control glycemic levels regularly, growing demand for lateral flow assays owing to its low cost and user-friendliness, and increasing demand for coagulation testing at physician’s office are the factors that are set to drive the growth of the Primary Care POC Diagnostics Market for the period 2021-2026.

Report Coverage

The report: “Primary Care POC Diagnostics Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Primary Care POC Diagnostics Market.
By Product Type: Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility Testing, Thyroid Testing, Hematology Testing, Lipid Testing, and Others.
By End User: Pharmacy and Retail Clinics, Physician Office, Urgent Care Clinics, and Others.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (Middle East and Africa).

Key Takeaways

  • Geographically, North America Primary Care POC Diagnostics Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the growing adoption of self-glucose testing devices in developed nations to control glycemic levels regularly.
  • The growing demand for coagulation testing at the physician’s office is driving the Physician Office segment. However, the stringent barriers faced by the key players owing to multi-layered regulations set by the Food and Drug Administration (FDA) is one of the major factors that is said to reduce the growth of the Primary Care POC Diagnostics Market.
  • Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Primary Care POC Diagnostics Market report.

Primary Care POC Diagnostics Market: Market Share (%) By End User, 2020


For More Details on This Report - Request for Sample

Primary Care POC Diagnostics Market Segment Analysis-By Product Type

The Primary Care POC Diagnostics Market based on the Product Type can be further segmented into Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility Testing, Thyroid Testing, Hematology Testing, Lipid Testing, and Others. The Glucose Testing segment held the largest share in 2020 and is also estimated to be the fastest growing segment with a CAGR of 4.8% over the period 2021-2026. This growth is owing to the factors such as the growing adoption of glucose testing to determine glucose levels in hospitalized patients and facilitate rapid treatment decisions in response to fluctuations in glycemia and increasing demand of glucometers to inform the doctor about the working of a medication regime. The rise in the adoption of self-glucose testing devices in developed nations to control glycemic levels regularly is driving the growth of the Primary Care POC Diagnostics Market. The Lipid Testing held the second largest share in 2020 owing to the factors such as the rise in the prevalence of target diseases such as cardiovascular diseases and dyslipidemia and growing favorable regulatory initiatives by the governments pertaining to diagnosis.

Primary Care POC Diagnostics Market Segment Analysis-By End user

The Primary Care POC Diagnostics Market based on the End User can be further segmented into the Pharmacy and Retail Clinics, Physician Office, Urgent Care Clinics, and Others. The Physician Office segment held the largest share in 2020 owing to the factors such as increasing demand for lateral flow assays in developed nations and rise in the consumer inclination towards stress-free and less time-consuming tests. The growing demand for coagulation testing at the physician’s office is driving the growth of the Primary Care POC Diagnostics Market. The Pharmacy and Retail Clinics segment is estimated to be the fastest growing segment with a CAGR of 4.5% over the period 2021-2026. This growth is owing to the factors such as the growing number of patients undergoing testing for chronic diseases at pharmacies and the rise in the availability of POC testing at pharmacies and retail clinics.

Primary Care POC Diagnostics Market Segment Analysis-By Geography

North America held the largest share with 33% of the overall market in 2020. The growth in this segment is owing to the factors such as the growing adoption of self-glucose testing devices in developed nations to control glycemic levels regularly and the rise in the demand for POC technologies from the pharmacy and retail clinics. The increasing demand for coagulation testing at the physician’s office is driving the growth of the Primary Care POC Diagnostics Market. Asia-Pacific segment is estimated to be the fastest growing segment over the period 2021-2026. The growth in this segment is owing to the factors such as growing demand for lateral flow assays laboratories for the qualitative and quantitative detection of specific antibodies and an increase in the efforts by the key players for the advancement of POC products at primary care.

Primary Care POC Diagnostics Market Drivers

Increase in the Demand for Lateral Flow Assays

Lateral flow assays are increasingly being used in physician's offices and clinical laboratories for the qualitative and quantitative detection of specific antibodies and also for products of gene amplification. Lateral flow assays have emerged as a well-established platform for primary care point-of-care (POC) testing owing to its low cost and user-friendliness, which is one of the major factors driving the growth of the Primary Care POC Diagnostics Market.

Rise in the Adoption of Glucose Testing in Primary Care POC Diagnostics

POC glucose testing has become a widely used tool to enable the determination of glucose levels in hospitalized patients and also to facilitate treatment decisions as a response to fluctuations in glycemia. POC glucose testing devices conveniently use whole blood measurements at the patient’s bedside and convert the results to plasma glucose concentrations, which is propelling the growth of the Primary Care POC Diagnostics Market.

Primary Care POC Diagnostics Market Challenges

Stringent Government Regulations

The key players across the world are making continuous efforts for the advancement of POC products concerning their portability to ensure effective and unrestricted usage of POC devices at primary care levels. However, the stringent barriers faced by the key players owing to multi-layered regulations set by the Food and Drug Administration (FDA) is one of the major factors that is estimated to reduce the growth of the Primary Care POC Diagnostics Market.

Primary Care POC Diagnostics Market Competitive Landscape:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Primary Care POC Diagnostics Market. Key companies of this market are Roche Diagnostics, Danaher Corporation, Abbott Laboratories, Siemens Healthcare, BioMerieux, Quidel Corporation, BD Biosciences, Thermo Fisher Scientific, Agilent Technologies, and Qiagen among others.

Acquisitions/Product Launches:

  • In January 2021, Thermo Fisher Scientific has acquired point-of-care diagnostics provider Mesa Biotech for $450 million in cash to develop point-of-care testing devices for infectious diseases in the future and to accelerate the availability of accurate advanced diagnostics at the point of care.
  • In May 2020, Roche Diagnostics has launched Roche v-TAC that can be used in point of care (POC) that allows clinicians to obtain results for arterial blood gas values from patients with respiratory abnormalities with a less invasive venous puncture by using a digital algorithm.
  • In March 2020, Abbott Laboratories has launched a point-of-care test to be made available and provide rapid results in a wide range of healthcare settings such as physicians' offices and urgent care clinics and also to provide positive results in five minutes.

Relevant Reports

Report Code: HCR 0068

Report Code: HCR 40147


For more Lifesciences and Healthcare Market reports, please click here

1. Primary Care POC Diagnostics Market - Overview
    1.1 Definitions and Scope
2. Primary Care POC Diagnostics Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product Type
    2.3 Key trends by End User
    2.4 Key trends by Geography
3. Primary Care POC Diagnostics Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Primary Care POC Diagnostics Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Primary Care POC Diagnostics Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Primary Care POC Diagnostics Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Primary Care POC Diagnostics Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Primary Care POC Diagnostics Market – By Product Type(Market Size –$Million/$Billion)
    8.1 Glucose Testing
    8.2 Hb1Ac Testing
    8.3 Coagulation Testing
    8.4 Fertility Testing
    8.5 Thyroid Testing
    8.6 Hematology Testing
    8.7 Lipid Testing
    8.8 Others
9. Primary Care POC Diagnostics Market – By End User(Market Size –$Million/$Billion)
    9.1 Pharmacy and Retail Clinics
    9.2 Physician Office
    9.3 Urgent Care Clinics
    9.4 Others
10. Primary Care POC Diagnostics Market - By Geography(Market Size –$Million/$Billion)
    10.1 North America
        10.1.1 U.S.
        10.1.2 Mexico
        10.1.3 Canada
    10.2 Europe
        10.2.1 U.K.
        10.2.2 France
        10.2.3 Germany
        10.2.4 Italy
        10.2.5 Spain
        10.2.6 Russia
        10.2.7 Rest of Europe
    10.3 Asia Pacific
        10.3.1 China
        10.3.2 India
        10.3.3 Japan
        10.3.4 South Korea
        10.3.5 Australia & New Zealand
        10.3.6 Rest of Asia Pacific
    10.4 South America
        10.4.1 Brazil
        10.4.2 Argentina
        10.4.3 Rest of South America
    10.5 Rest of the World
        10.5.1 Middle East
        10.5.2 Africa
11. Primary Care POC Diagnostics Market - Entropy
12. Primary Care POC Diagnostics Market – Industry/Segment Competition Landscape Premium
    12.1 Market Share Analysis
        12.1.1 Global Market Share – Key Companies
        12.1.2 Market Share by Region – Key companies
        12.1.3 Market Share by Countries – Key Companies
        12.1.4 Best Practices for Companies
13. Primary Care POC Diagnostics Market – Key Company List by Country Premium Premium
14. Primary Care POC Diagnostics Market Company Analysis
    14.1 Company 1
    14.2 Company 2
    14.3 Company 3
    14.4 Company 4
    14.5 Company 5
    14.6 Company 6
    14.7 Company 7
    14.8 Company 8
    14.9 Company 9
    14.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Competitive Landscape: Market 2023-2030 ($M)
1.1 Market participation categorization Market 2023-2030 ($M) - Global Industry Research
2.Global Competitive Landscape: Market 2023-2030 (Volume/Units)
2.1 Market participation categorization Market 2023-2030 (Volume/Units) - Global Industry Research
3.North America Competitive Landscape: Market 2023-2030 ($M)
3.1 Market participation categorization Market 2023-2030 ($M) - Regional Industry Research
4.South America Competitive Landscape: Market 2023-2030 ($M)
4.1 Market participation categorization Market 2023-2030 ($M) - Regional Industry Research
5.Europe Competitive Landscape: Market 2023-2030 ($M)
5.1 Market participation categorization Market 2023-2030 ($M) - Regional Industry Research
6.APAC Competitive Landscape: Market 2023-2030 ($M)
6.1 Market participation categorization Market 2023-2030 ($M) - Regional Industry Research
7.MENA Competitive Landscape: Market 2023-2030 ($M)
7.1 Market participation categorization Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Primary Care POC Diagnostics Market Revenue, 2023-2030 ($M)
2.Canada Primary Care POC Diagnostics Market Revenue, 2023-2030 ($M)
3.Mexico Primary Care POC Diagnostics Market Revenue, 2023-2030 ($M)
4.Brazil Primary Care POC Diagnostics Market Revenue, 2023-2030 ($M)
5.Argentina Primary Care POC Diagnostics Market Revenue, 2023-2030 ($M)
6.Peru Primary Care POC Diagnostics Market Revenue, 2023-2030 ($M)
7.Colombia Primary Care POC Diagnostics Market Revenue, 2023-2030 ($M)
8.Chile Primary Care POC Diagnostics Market Revenue, 2023-2030 ($M)
9.Rest of South America Primary Care POC Diagnostics Market Revenue, 2023-2030 ($M)
10.UK Primary Care POC Diagnostics Market Revenue, 2023-2030 ($M)
11.Germany Primary Care POC Diagnostics Market Revenue, 2023-2030 ($M)
12.France Primary Care POC Diagnostics Market Revenue, 2023-2030 ($M)
13.Italy Primary Care POC Diagnostics Market Revenue, 2023-2030 ($M)
14.Spain Primary Care POC Diagnostics Market Revenue, 2023-2030 ($M)
15.Rest of Europe Primary Care POC Diagnostics Market Revenue, 2023-2030 ($M)
16.China Primary Care POC Diagnostics Market Revenue, 2023-2030 ($M)
17.India Primary Care POC Diagnostics Market Revenue, 2023-2030 ($M)
18.Japan Primary Care POC Diagnostics Market Revenue, 2023-2030 ($M)
19.South Korea Primary Care POC Diagnostics Market Revenue, 2023-2030 ($M)
20.South Africa Primary Care POC Diagnostics Market Revenue, 2023-2030 ($M)
21.North America Primary Care POC Diagnostics By Application
22.South America Primary Care POC Diagnostics By Application
23.Europe Primary Care POC Diagnostics By Application
24.APAC Primary Care POC Diagnostics By Application
25.MENA Primary Care POC Diagnostics By Application